Cost-Effectiveness Analysis of Apixaban Versus Dabigatran for Prevention of Stroke in Patients with Non-Valvular Atrial Fibrillation in Spain
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1265
https://www.valueinhealthjournal.com/article/S1098-3015(13)03170-7/fulltext
Title :
Cost-Effectiveness Analysis of Apixaban Versus Dabigatran for Prevention of Stroke in Patients with Non-Valvular Atrial Fibrillation in Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03170-7&doi=10.1016/j.jval.2013.08.1265
First page :
A523
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1113